NCT04601168

Brief Summary

Decathlon has developed kneeSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon kneeSOFT100 product to demonstrate safety and performance of this device in a real-world setting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 23, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

March 25, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2022

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

1.3 years

First QC Date

September 4, 2020

Last Update Submit

September 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional score

    Comparison of the functional result (Lysholm Score: 0-100 points) between the baseline and last follow-up visit

    6 weeks of follow-up

Secondary Outcomes (4)

  • Confidence level

    At baseline and 6 weeks of follow-up

  • Knee instability

    At 2 weeks and 6 weeks of follow-up

  • Knee pain

    At 2 weeks and 6 weeks of follow-up

  • Safety (adverse events)

    6 weeks of follow-up

Interventions

During the first two weeks of follow-up, the subject shall not use the device during the sports sessions. The subject shall use the device during the sports sessions for the next 4 weeks (6 weeks of follow-up)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subject with chronic pain AND / OR chronic knee instability whose current condition of his/her knee allows him/her to pursue a usual physical activity.

You may qualify if:

  • Subject is aged ≥18 years old
  • Subject has chronic pain AND / OR chronic knee instability
  • The current condition of his/her knee allows the subject to resume usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
  • Subject is affiliated to the French social security regime

You may not qualify if:

  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (knee brace or articulated orthosis) during sports sessions during the last month
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the device (elastodiene, polyester)
  • Adult subject to a legal protection measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire de Lille

Lille, 59000, France

Location

KOSS Paris 8

Paris, France

Location

Study Officials

  • Valérie WIECZOREK

    Centre Hospitalier Universitaire de Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2020

First Posted

October 23, 2020

Study Start

March 25, 2021

Primary Completion

July 19, 2022

Study Completion

July 19, 2022

Last Updated

September 14, 2022

Record last verified: 2022-09

Locations